Dermatology News and Research

Latest Dermatology News and Research

Issues and treatments of chronic skin wounds

The skin is the body's largest organ and an indispensable part of the immune system. As the body's outermost line of defense against microbes, the skin provides important protection against potentially toxic environmental elements. One subset of immune cells, thymus-derived T-cells play an important role in the skin's response to injury, particularly with respect to wound healing.

21 Mar 2012

ISCO fourth quarter revenue increases 110% to $1.1 million

International Stem Cell Corporation today announced year-end financial results for the year ended December 31, 2011.

21 Mar 2012

IGI fourth quarter total revenues increase 21% to $2.1M

IGI Laboratories, Inc., a New Jersey based topical generic drug development and manufacturing company, provided its financial results for the fourth quarter and year ended December 31, 2011.

21 Mar 2012

Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.

20 Mar 2012

Styling practices linked with hair or scalp diseases among African Americans

Styling practices can lead to serious hair and scalp diseases for some African Americans, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.

20 Mar 2012

Merz launches new, once daily Mederma Advanced Scar Gel

Mederma, the #1 doctor-and pharmacist-recommended brand for scars for over a decade, announced today the introduction of Mederma Advanced Scar Gel, which reduces the overall appearance of scars caused by injury, acne, surgery or burns with just one daily application. Mederma Advanced Scar Gel contains Cepalin, the same proprietary botanical extract derived from onions used in all Mederma® scar products and stretch marks therapy.

19 Mar 2012

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis.

19 Mar 2012

Study of genes may hold the key to improved skin care

Ever wonder why two people who are the same age may look years apart? While extrinsic factors such as sun exposure and smoking can contribute to skin aging, intrinsic factors - namely the genes inherited from our parents - can have an even greater influence on how our skin ages.

17 Mar 2012

ZO Skin Health to launch new comprehensive medical skincare line

ZO Skin Health By Zein Obagi, M.D. is pleased to announce the global launch of a new comprehensive medical skincare line, ZO Medical, at the American Academy of Dermatology Annual Meeting.

17 Mar 2012

APN forms GPO partnership with ASDS

Aesyntix Physician Network (APN), a group purchasing organization (GPO) for dermatology and cosmetic surgery practices, and the American Society for Dermatologic Surgery (ASDS) today announced they have formed a partnership to provide ASDS members with significant savings opportunities on commonly purchased medical/surgical supplies and other products and services, including Revenue Cycle Management solutions.

17 Mar 2012

Einstein members celebrate 2012 Match Day

Members of Albert Einstein College of Medicine of Yeshiva University's graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year's Match Day. Representing the culmination of their medical school education, Match Day marked the transition of Einstein's class of 2012 into the post-graduate phase of their training - when they will practice medicine in a clinical setting under the supervision of fully licensed physicians.

17 Mar 2012

Adalimumab may decrease vascular inflammation in patients with psoriasis

A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.

17 Mar 2012

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.

17 Mar 2012

Clear link between androgenetic alopecia and benign prostate hyperplasia

Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH), a benign enlargement of the prostate that appears in aging men and is associated with certain hormones as dihydrotestosterone. This condition appears in 50% of men over 60 year old and causes voiding syndrome i.e. urinary frequency.

16 Mar 2012

FDA clears Alma Lasers' novel approach for treatment of nail fungus

For the 35 million people worldwide that suffer from Onychomycosis (nail fungus), a new, fast, effective approach to treatment is now available. Alma Lasers, Inc., a leader in laser, light, radiofrequency and ultrasound aesthetic and medical devices, is pleased to announce the introduction of its newest innovation for the Harmony(XL) multi-application, multi-technology platform, a novel approach for the treatment of nail fungus.

16 Mar 2012

Combined therapy effective in treating patients with severe facial acne

A combined therapy of common acne medications was shown to be a potent regimen for treating patients with severe facial acne, according to two published studies involving Henry Ford Hospital.

15 Mar 2012

New topical gel decreases amount of time needed to treat actinic keratosis

A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine.

15 Mar 2012

Researchers identify specific gene linked with throat cancer

Researchers at King's College London and Hiroshima University, Japan, have identified a specific gene linked to throat cancer following a genetic study of a family with 10 members who have developed the condition.

8 Mar 2012

Researchers reveal how melanoma develops resistance to Zelboraf

Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene.

7 Mar 2012

KYTHERA commences two ATX-101 Phase III trials for reduction of submental fat

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the initiation of two pivotal U.S. Phase III trials of ATX-101, a first-in-class injectable drug under clinical investigation for the reduction of submental (under the chin) fat.

5 Mar 2012